Imagine discovering your newborn has a devastating disease that could have been caught early—but wasn't. This is the heartbreaking reality Jesy Nelson is fighting to change. The former Little Mix singer has launched a passionate campaign to ensure all babies are screened for Spinal Muscular Atrophy (SMA) at birth, a rare but severe condition her twin daughters were recently diagnosed with. But here's where it gets controversial: while Scotland is set to introduce routine SMA screening this spring, the rest of the UK is still reviewing the decision. Why the delay? And this is the part most people miss: early detection can be life-changing, especially with groundbreaking treatments like Zolgensma now available on the NHS. Yet, SMA isn’t currently included in the standard newborn blood test, which screens for other conditions like cystic fibrosis. Nelson’s petition demands SMA be added to this test, arguing it’s a matter of urgency. In an emotional Instagram post, she shared her daughters’ diagnosis, revealing they may never walk or regain full neck strength. “It’s like watching your child’s muscles slowly fade,” she explained, highlighting the disease’s relentless progression. But is the NHS moving fast enough? Health Secretary Wes Streeting agrees Nelson’s criticism is valid, promising to prioritize SMA screening and genomic medicine. Yet, questions remain: Why isn’t SMA already part of routine screening? And could earlier action have saved families from this agony? The NHS counters that three new SMA treatments since 2019 have helped hundreds of children, but advocates like Nelson argue prevention is key. The National Screening Committee is reviewing the issue, but time is ticking for families like hers. What do you think? Should SMA screening be fast-tracked, or is the NHS right to proceed cautiously? Share your thoughts below—this debate needs your voice.
